NCT04904146View on ClinicalTrials.gov

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 2, 2021

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Mycosis FungoidesSezary Syndrome
Interventions
DIAGNOSTIC_TEST

Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.

The study aims to perform systematic translational sampling of each patient from study start until end-of-study, or at longest for a three year period for each patient. Treatment will be performed according to clinical routine.

Trial Locations (1)

SE-221 85

RECRUITING

Lund University Hospital, Lund

All Listed Sponsors
lead

Lund University Hospital

OTHER